No JH - Search Results

1

Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries.

No JH. No JH. Acta Trop. 2016 Mar;155:113-23. doi: 10.1016/j.actatropica.2015.12.016. Epub 2015 Dec 31. Acta Trop. 2016. PMID: 26748356 Review.

2

Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite.

Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S. Zahedifard F, et al. Among authors: no jh. Exp Parasitol. 2020 Feb;209:107823. doi: 10.1016/j.exppara.2019.107823. Epub 2019 Dec 17. Exp Parasitol. 2020. PMID: 31862270

3

Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.

Lee H, Baek KH, Phan TN, Park IS, Lee S, Kim J, No JH. Lee H, et al. Among authors: no jh. Biochem Biophys Res Commun. 2021 Sep 10;569:193-198. doi: 10.1016/j.bbrc.2021.07.019. Epub 2021 Jul 10. Biochem Biophys Res Commun. 2021. PMID: 34256188

4

Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani.

McNamara N, Saunders E, Varghese S, Zheng R, Simpson K, Varma DM, Johnson MM, Hasan Zahid MS, Bachelder EM, Ainslie KM, No JH, Koh D, Shum D, Das N, Patra B, Roy J, Talukdar A, Ganguly D, McConville M, Baell J. McNamara N, et al. Among authors: no jh. Eur J Med Chem. 2022 Oct 5;240:114577. doi: 10.1016/j.ejmech.2022.114577. Epub 2022 Jul 1. Eur J Med Chem. 2022. PMID: 35810535

5

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Durieu E, Prina E, Leclercq O, Oumata N, Gaboriaud-Kolar N, Vougogiannopoulou K, Aulner N, Defontaine A, No JH, Ruchaud S, Skaltsounis AL, Galons H, Späth GF, Meijer L, Rachidi N. Durieu E, et al. Among authors: no jh. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2822-33. doi: 10.1128/AAC.00021-16. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26902771 Free PMC article.

6

In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei.

Phan TN, Baek KH, Lee N, Byun SY, Shum D, No JH. Phan TN, et al. Among authors: no jh. Molecules. 2020 Apr 23;25(8):1980. doi: 10.3390/molecules25081980. Molecules. 2020. PMID: 32340370 Free PMC article.

7

Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei.

Sun YN, No JH, Lee GY, Li W, Yang SY, Yang G, Schmidt TJ, Kang JS, Kim YH. Sun YN, et al. Among authors: no jh. Molecules. 2016 Apr 12;21(4):480. doi: 10.3390/molecules21040480. Molecules. 2016. PMID: 27077842 Free PMC article.

8

Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts.

Yang G, Choi G, No JH. Yang G, et al. Among authors: no jh. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6828-6836. doi: 10.1128/AAC.01129-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27600039 Free PMC article.

9

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.

Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, Rafati S. Zahedifard F, et al. Among authors: no jh. PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0007217. doi: 10.1371/journal.pntd.0007217. eCollection 2019 Feb. PLoS Negl Trop Dis. 2019. PMID: 30811391 Free PMC article.

10

Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations.

Baek KH, Piel L, Rosazza T, Prina E, Späth GF, No JH. Baek KH, et al. Among authors: no jh. Pathogens. 2020 May 20;9(5):393. doi: 10.3390/pathogens9050393. Pathogens. 2020. PMID: 32443883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page